Liz Essley

Liz Essley Whyte is a reporter in The Wall Street Journal's D.C. bureau, covering the intersection of the life sciences and Washington. Before joining the Journal in 2022, she was an investigative reporter at the Center for Public Integrity, a nonprofit newsroom, where for several years she covered statehouse lobbying, campaign finance and ballot measures. Her investigations spurred lawmakers to propose federal legislation and investigate a state Medicaid official. She was part of reporting teams that won Goldsmith and Loeb awards. She began her career covering local transportation for the Washington Examiner.

Biography:  https://www.wsj.com/news/author/liz-essley-whyte

98%

The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermines the credibility of the source. It is calculated as:
Analysis.OverallConflictOfInterestScore * 0.3F + Analysis.OverallBiasScore * 0.3F + Analysis.DeceptivenessScore * 0.3F + Analysis.ReadabilityScore * 0.1F

A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

The Daily's Verdict

This author is known for its high journalistic standards. The author strives to maintain neutrality and transparency in its reporting, and avoids conflicts of interest. The author has a reputation for accuracy and rarely gets contradicted on major discrepancies in its reporting.

Bias

100%

Examples:

No current examples available.

Conflicts of Interest

100%

Examples:

No current examples available.

Contradictions

100%

Examples:

No current examples available.

Deceptions

100%

Examples:

No current examples available.

Recent Articles

Florida Granted First State to Import Prescription Drugs from Canada, Pharmaceutical Companies Fight Back

Florida Granted First State to Import Prescription Drugs from Canada, Pharmaceutical Companies Fight Back

Broke On: Friday, 05 January 2024 Florida becomes the first state to import prescription drugs from Canada, in a bid to reduce costs. However, pharmaceutical companies have already signaled their intention to fight this plan.